0001209191-15-047728.txt : 20150528 0001209191-15-047728.hdr.sgml : 20150528 20150528192514 ACCESSION NUMBER: 0001209191-15-047728 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150526 FILED AS OF DATE: 20150528 DATE AS OF CHANGE: 20150528 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PHARMACYCLICS INC CENTRAL INDEX KEY: 0000949699 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943148201 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: PHARMACYCLICS INC STREET 2: 995 E ARQUES AVE CITY: SUNNYVALE STATE: CA ZIP: 94085-4521 BUSINESS PHONE: 408 774 0330 MAIL ADDRESS: STREET 1: PHARMACYCLICS INC STREET 2: 995 E ARQUES AVE CITY: SUNNYVALE STATE: CA ZIP: 94085-4521 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HALVORSON ERIC H CENTRAL INDEX KEY: 0001190985 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26658 FILM NUMBER: 15896861 MAIL ADDRESS: STREET 1: 4880 SANTA ROSA RD CITY: CAMARILLO STATE: CA ZIP: 93012 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-05-26 0 0000949699 PHARMACYCLICS INC PCYC 0001190985 HALVORSON ERIC H C/O PHARMACYCLICS, INC. 995 EAST ARQUES AVENUE SUNNYVALE CA 94085 1 0 0 0 Common Stock 2015-05-26 4 U 0 1000 261.25 D 0 D Stock Option (Right to Buy) 14.26 2015-05-26 4 D 0 12500 D 2021-12-15 Common Stock 12500 0 D Stock Option (Right to Buy) 59.28 2015-05-26 4 D 0 515 D 2022-07-02 Common Stock 515 0 D Stock Option (Right to Buy) 65.56 2015-05-26 4 D 0 466 D 2022-10-01 Common Stock 466 0 D Stock Option (Right to Buy) 49.00 2015-05-26 4 D 0 7500 D 2022-11-09 Common Stock 7500 0 D Stock Option (Right to Buy) 61.44 2015-05-26 4 D 0 522 D 2023-01-02 Common Stock 522 0 D Stock Option (Right to Buy) 79.67 2015-05-26 4 D 0 344 D 2023-04-01 Common Stock 344 0 D Stock Option (Right to Buy) 74.48 2015-05-26 4 D 0 3750 D 2023-05-09 Common Stock 3750 0 D Stock Option (Right to Buy) 85.39 2015-05-26 4 D 0 340 D 2023-07-01 Common Stock 340 0 D Stock Option (Right to Buy) 139.89 2015-05-26 4 D 0 195 D 2023-10-01 Common Stock 195 0 D Stock Option (Right to Buy) 108.44 2015-05-26 4 D 0 252 D 2024-01-02 Common Stock 252 0 D Stock Option (Right to Buy) 107.42 2015-05-26 4 D 0 267 D 2024-04-01 Common Stock 267 0 D Stock Option (Right to Buy) 95.08 2015-05-26 4 D 0 3750 D 2024-05-09 Common Stock 3750 0 D Stock Option (Right to Buy) 89.58 2015-05-26 4 D 0 440 D 2024-07-01 Common Stock 440 0 D Stock Option (Right to Buy) 115.80 2015-05-26 4 D 0 327 D 2024-10-01 Common Stock 327 0 D Stock Option (Right to Buy) 124.46 2015-05-26 4 D 0 306 D 2025-01-02 Common Stock 306 0 D Stock Option (Right to Buy) 257.015 2015-05-26 4 D 0 187 D 2025-04-07 Common Stock 187 0 D Price reflects aggregate per share consideration paid pursuant to the Tender Offer. Pursuant to terms of the Agreement and Plan of Reorganization (the "Merger Agreement") dated March 4, 2015, by and between the Issuer, AbbVie Inc., a Delaware corporation ("AbbVie"), Oxford Amherst Corporation, a Delaware corporation and a direct wholly owned subsidiary of AbbVie and Oxford Amherst LLC, a Delaware limited liability company and a direct wholly owned subsidiary of AbbVie this option was cancelled in exchange for a cash payment equal to the number of shares subject to the option multiplied by the difference between $261.25 and the exercise price of the option, subject to applicable withholding taxes and pursuant to the procedures set forth in the Merger Agreement. /s/ Eric Halvorson 2015-05-27